Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:1.6.3.1 (
NADPH oxidase
)
11,281
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Exposure of neutrophils to LPS (lipopolysaccharide) triggers their oxidative response. However, the relationship between the signalling downstream of TLR4 (Toll-like receptor 4) after LPS stimulation and the activation of the oxidase remains elusive. Phosphorylation of the cytosolic factor p47phox is essential for activation of the
NADPH oxidase
. In the present study, we examined the hypothesis that
IRAK-4
(interleukin-1 receptor-associated kinase-4), the main regulatory kinase downstream of TLR4 activation, regulates the
NADPH oxidase
through phosphorylation of p47phox. We show that p47phox is a substrate for
IRAK-4
. Unlike PKC (protein kinase C),
IRAK-4
phosphorylates p47phox not only at serine residues, but also at threonine residues. Target residues were identified by tandem MS, revealing a novel threonine-rich regulatory domain. We also show that p47phox is phosphorylated in granulocytes in response to LPS stimulation. LPS-dependent phosphorylation of p47phox was enhanced by the inhibition of p38 MAPK (mitogen-activated protein kinase), confirming that the kinase operates upstream of p38 MAPK.
IRAK-4
-phosphorylated p47phox activated the
NADPH oxidase
in a cell-free system, and
IRAK-4
overexpression increased
NADPH oxidase
activity in response to LPS. We have shown that endogenous
IRAK-4
interacts with p47phox and they co-localize at the plasma membrane after LPS stimulation, using immunoprecipitation assays and immunofluorescence microscopy respectively.
IRAK-4
was activated in neutrophils in response to LPS stimulation. We found that Thr133, Ser288 and Thr356, targets for
IRAK-4
phosphorylation in vitro, are also phosphorylated in endogenous p47phox after LPS stimulation. We conclude that
IRAK-4
phosphorylates p47phox and regulates
NADPH oxidase
activation after LPS stimulation.
...
PMID:Cross-talk between IRAK-4 and the NADPH oxidase. 1721 39